<DOC>
	<DOC>NCT00088205</DOC>
	<brief_summary>The purposes of this study are to determine the safety of oral enzastaurin HCl and any side effects that might be associated with it and whether enzastaurin HCl can help patients with Mantle Cell Lymphoma.</brief_summary>
	<brief_title>Oral Enzastaurin HCl in Patients With Relapsed Mantle Cell Lymphoma</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma, Mantle-Cell</mesh_term>
	<criteria>Mantle Cell Lymphoma Previous treatment for Mantle Cell Lymphoma Adequate organ function Inability to swallow tablets Must not have had more than 3 prior treatments for Mantle Cell Lymphoma Must not have significant heart problems</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>